CTLA4 and acute myeloid leukemia: In preclinical studies, CTLA-4 blockade in murine bone marrow chimeras induced potent anti-leukemic activity while avoiding graft-versus-host disease (GVHD), suggesting the potential value of adjuvant CTLA-4 blockade following allo-SCT in AML.